4-(Morpholin-4-yl)-6-phenyl-2-(pyridin-3-yl)pyrimidine-5-carbonitrile

Catalog No. :
ACUUJA128
CAS No. :
320417-69-4
Molecular Formula :
C20H17N5O
Molecular Weight :
343.39

IUPAC Name:4-morpholino-6-phenyl-2-(pyridin-3-yl)pyrimidine-5-carbonitrile

4-(Morpholin-4-yl)-6-phenyl-2-(pyridin-3-yl)pyrimidine-5-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$567.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Morpholin-4-yl)-6-phenyl-2-(pyridin-3-yl)pyrimidine-5-carbonitrile
IUPAC Name4-morpholino-6-phenyl-2-(pyridin-3-yl)pyrimidine-5-carbonitrile
MDL No.MFCD00139455
Molecular FormulaC20H17N5O
Molecular Weight343.39
SMILESN#CC1=C(C2=CC=CC=C2)N=C(C3=CC=CN=C3)N=C1N4CCOCC4
InChI KeyHORSLSDSHRJGDD-UHFFFAOYSA-N
Synonym4-MORPHOLINO-6-PHENYL-2-(3-PYRIDINYL)-5-PYRIMIDINECARBONITRILE;4-(morpholin-4-yl)-6-phenyl-2-(pyridin-3-yl)pyrimidine-5-carbonitrile;5-Pyrimidinecarbonitrile, 4-(4-morpholinyl)-6-phenyl-2-(3-pyridinyl)-
CAS No.320417-69-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACUUJA128 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPGVQ689 route compound structure diagram
    ACPGVQ6891692-25-7 In Stock
  4. Then
  5. ACUUJA128 route product structure diagram
    ACUUJA128320417-69-4
Inquiry

2. ACUUJA128 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUUJA128 route product structure diagram
    ACUUJA128320417-69-4
Inquiry

Comments (0)